ArticleInternational journal of clinical oncology2014

Weekly, low-dose docetaxel combined with estramustine for Japanese castration-resistant prostate cancer: its efficacy and safety profile compared with tri-weekly standard-dose treatment.

Yasutomo Nakai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.